Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vigonvita Life Sciences CoHKSE:02630 -4.62%8 Days Inventory is 80.74 as of Dec. 2025, which is 44% below its 10-year median of 143.77. GuruFocus rates HKSE:02630 with a GF Score™ of 8/100. The stock has 2 warning signs investors should review. Among 920 Drug Manufacturers companies, Vigonvita Life Sciences Co ranks better than 85.98% on this metric.
The historical rank and industry rank for Vigonvita Life Sciences Co's Days Inventory or its related term are showing as below:
HKSE:02630'
s Days Inventory Range Over the Past 10 Years
Min: 80.74 Med: 143.77 Max: 194.76
Current: 80.74
During the past 3 years, Vigonvita Life Sciences Co's highest Days Inventory was 194.76. The lowest was 80.74. And the median was 143.77.
HKSE:02630's Days Inventory is ranked better than 85.98% of 920
companies
in the Drug Manufacturers industry
Industry Median: 164.815
vs HKSE:02630: 80.74
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Vigonvita Life Sciences Co's Inventory Turnover for the
six
months ended in Dec. 2025 was 4.52.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vigonvita Life Sciences Co's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.05.
Vigonvita Life Sciences Co (HKSE:02630) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Vigonvita Life Sciences Co's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vigonvita Life Sciences Co's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Vigonvita Life Sciences Co Days Inventory Related Terms
Vigonvita Life Sciences Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vigonvita Life Sciences Co Days Inventory Chart
Vigonvita Life Sciences Co Annual Data
Trend
Dec23
Dec24
Dec25
Days Inventory
194.76
143.77
80.74
Vigonvita Life Sciences Co Semi-Annual Data
Dec23
Dec24
Dec25
Days Inventory
194.76
143.77
80.74
HKSE:02630 vs LLY, JNJ, ABBV: Days Inventory Comparison
For the Drug Manufacturers - General subindustry, Vigonvita Life Sciences Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vigonvita Life Sciences Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vigonvita Life Sciences Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Vigonvita Life Sciences Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vigonvita Life Sciences Co (HKSE:02630) has a Days Inventory of 80.74 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vigonvita Life Sciences Co and its competitors. This is 44% below median its historical median of 143.77. Over the past decade, Vigonvita Life Sciences Co's Days Inventory has ranged from 80.74 to 194.76. According to the industry distribution chart, Vigonvita Life Sciences Co ranks #129 out of 920 companies in the Drug Manufacturers industry, placing it in the top 14%.
Is Vigonvita Life Sciences Co's Days Inventory too high?
Vigonvita Life Sciences Co's current Days Inventory of 80.74 is 44% below median its 10-year median of 143.77. Over the past 10 years, this metric has ranged from a low of 80.74 to a high of 194.76. The Drug Manufacturers industry median Days Inventory is 164.82. Vigonvita Life Sciences Co's value of 80.74 is 51% below this industry median. Based on the distribution chart, Vigonvita Life Sciences Co ranks #129 out of 920 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Vigonvita Life Sciences Co has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Vigonvita Life Sciences Co's Days Inventory compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Vigonvita Life Sciences Co ranks #129 out of 920 companies for Days Inventory. This places Vigonvita Life Sciences Co in the top 14% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.82. Vigonvita Life Sciences Co's value of 80.74 is 51% below this benchmark. Historically, Vigonvita Life Sciences Co's own Days Inventory has ranged from 80.74 to 194.76 over the past decade. While the company's 10-year median is 143.77 vs. the industry median of 164.82, Vigonvita Life Sciences Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.82, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vigonvita Life Sciences Co's current Days Inventory of 80.74 is 51% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vigonvita Life Sciences Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vigonvita Life Sciences Co's current Days Inventory is 80.74, which is 44% below median its own 10-year median of 143.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vigonvita Life Sciences Co stock overvalued right now?
Vigonvita Life Sciences Co (HKSE:02630) has a current Days Inventory of 80.74. The current Days Inventory is 80.74, which is 44% below median its 10-year median of 143.77 and 51% below the Drug Manufacturers industry median of 164.82. Vigonvita Life Sciences Co's overall GF Score™ is 8/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Vigonvita Life Sciences Co (HKSE:02630), the current Days Inventory is 80.74 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vigonvita Life Sciences Co Ltd biopharmaceutical company. It is focused on innovation driven biopharmaceutical development, with a strategic emphasis on addressing unmet clinical needs in the treatment of neuropsychiatric, infectious, and andrological diseases. The company's core Products include LV232, anti-depression drug candidate, VV913: a novel investigational drug candidate for premature ejaculation and, VV116: an oral nucleoside analog with broad-spectrum antiviral potential. The company's operations are located in the PRC and Uzbekistan. Revenue is generated from the out-licensing and the sales of its pharmaceutical products.
8GF Score
Get the complete analysis for HKSE:02630
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02630 has been successfully added to your 
